Supreme Pharmaceuticals (SPRWF) 0.0530 $SPRWF
Supreme Grants Incentive Options
Marketwire - Wed May 07, 5:07AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(CSE: SL)(OTCBB: SPRWF) has granted 12,000,000 incentive stock options to directors, officers and consultants at an exercise price of $0.05 for a term of five years from this day May 5th, 2014.
In the Medical Marijuana Market, Pick a Winner
GlobeNewswire - Thu May 01, 9:40AM CDT
Most savvy investors are aware of the recent surge in interest in the Medical Marijuana and Industrial Hemp space. The sector is quickly developing, as new Federal rules kicked in April 1 2014. It is important for investors to align themselves with companies that will actually deliver. There are several market figures floating around, but safe to say the market will grow exponentially over the next 5-10 years. Early exposure is likely warranted.
Supreme Extends Due Diligence and Cancels Private Placement
Marketwire - Tue Apr 15, 8:52AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (OTCBB: SPRWF)(TSX VENTURE: SL) reports that the parties to the agreement to acquire the South Okanagan producing medical marijuana facility, have mutually agreed upon an extension of the due diligence period to April 29th, 2014.
Supreme Enters Into Negotiations for an Additional Medical Marijuana Producing Facility
Marketwire - Mon Apr 14, 7:03AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (OTCBB: SPRWF) (TSX VENTURE: SL) reports that the Company has entered into negotiations with a producing medical marijuana facility to acquire that business. This is in addition to the South Okanagan producing facility currently under evaluation. The parties have agreed to an exclusive 45-day negotiating period. There is no guarantee that an agreement will be reached and will subject to regulatory approval.
Supreme Pharmaceuticals Inc.: Due Diligence Update
Marketwire - Wed Apr 09, 3:16PM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(PINKSHEETS: SPRWF) notes that in respect to its prior press release on Friday April 4, 2014, the Company will be utilizing the full 7 business days to complete and conclude the due diligence period. This means that the Company will report news on Tuesday, April 15, 2014 with a final decision on the South Okanagan producing medical marijuana facility.
Supreme Extends Due Diligence Period
Marketwire - Fri Apr 04, 2:35PM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(OTCBB: SPRWF) reports that the parties have extended the due diligence period in respect to the Company's peviously announced option agreement for an additional 7 business days until April 10, 2014. While due diligence results have been positive to date, the Company requires additional time to ensure the proper assessment of the South Okanagan producing facility before entering into the option.
Supreme Pharmaceuticals Inc.: Executive Management Visits Producing Facility as Part of Due Diligence
Marketwire - Tue Apr 01, 8:27AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (OTCBB: SPRWF)(TSX VENTURE: SL) advises that management is currently visiting the producing medical marijuana facility on which the Company may acquire an option to purchase, as part of its due diligence. The facility is located in the south Okanagan and the Company will get an onsite evaluation of the complex as it enters the final stages of the due diligence period. The 10 day due diligence period expires as of Friday April 4th, 2014. There is no assurance that the normal due diligence and other conditions will be met successfully and the option acquired. The Company will provide further updates as this matter progresses.
Cannabis Companies Continue To Ramp Up Operations: High Tech Security Company Expands Presence In Colorado
PR Newswire - Tue Mar 25, 9:45AM CDT
New licensing Agreements, Grow Monitoring Applications and High Tech Security surveillance operations aims to capitalize on cannabis - medical marijuana boom with expansion in Colorado: DirectView Holdings, Inc. (OTC: DIRV), Growlife, Inc. (OTC: PHOT), Nuvilex, Inc. (OTC: NVLX), IMD Companies, Inc. (OTC: ICBU) and Supreme Pharmaceuticals Inc. (OTC: SPRWF)
Supreme Updates Option to Purchase Press Release and Announces Private Placement
Marketwire - Tue Mar 25, 8:58AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(OTCBB: SPRWF) is pleased to announce that the Company has signed a conditional agreement with an arms-length South Okanagan-based company, whereby the Company has the option to purchase its producing medical marijuana business until March 23, 2015 for the sum of $1,000,000, payable in cash and shares, subject to regulatory approval. The Company is currently in a 10-business day due diligence period and if satisfied, Supreme will, subject to prior approval of the TSXV, make a $100,000 option payment.
Supreme Acquires Option to Purchase Producing Medical Marijuana Facility
Marketwire - Mon Mar 24, 2:02AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(OTCBB: SPRWF) is pleased to announce that the Company has signed a conditional agreement with an arms-length South Okanagan-based company, whereby the Company has the option to purchase its producing medical marijuana business for up to twelve months for the sum of $1,000,000, payable in cash and shares, subject to regulatory approval. The Company is currently in a 10-business day due diligence period and if satisfied, Supreme will make a $100,000 option payment.
Supreme to Evaluate Medical Marijuana Opportunities
Marketwire - Fri Mar 21, 7:01AM CDT
Supreme Pharmaceuticals Inc. (the "Company" (TSX VENTURE: SL)(OTCBB: SPRWF) is pleased to announce that its continued efforts to secure an exclusive license agreement for a medical device are making significant headway; the Company will continue to keep its shareholders up to date on negotiations. In addition to medical devices, the Company has recently come across opportunities within the medical marijuana industry. Companies and key contacts have approached management with opportunities and the Company is evaluating them accordingly. Given the medical marijuana industry's immense growth, management is excited to evaluate the merit of the opportunities.
Supreme Announces Name Change and Provides Update
Marketwire - Fri Mar 14, 3:01AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Corporation" (TSX VENTURE: SL)(OTCBB: SPRWF), formerly Supreme Resources Ltd., announces that it has changed its name to Supreme Pharmaceuticals Inc. in conjunction with its recent decision to pursue interests in pharmaceuticals and biomedical devices. The TSX Venture Exchange has advised the Corporation that trading under the new name and symbol "SL" will commence on March 14, 2014.
Supreme Grants Incentive Options
Marketwire - Wed May 07, 5:07AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(CSE: SL)(OTCBB: SPRWF) has granted 12,000,000 incentive stock options to directors, officers and consultants at an exercise price of $0.05 for a term of five years from this day May 5th, 2014. In the Medical Marijuana Market, Pick a Winner
GlobeNewswire - Thu May 01, 9:40AM CDT
Most savvy investors are aware of the recent surge in interest in the Medical Marijuana and Industrial Hemp space. The sector is quickly developing, as new Federal rules kicked in April 1 2014. It is important for investors to align themselves with companies that will actually deliver. There are several market figures floating around, but safe to say the market will grow exponentially over the next 5-10 years. Early exposure is likely warranted.
Supreme Extends Due Diligence and Cancels Private Placement
Marketwire - Tue Apr 15, 8:52AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(OTCBB: SPRWF)(TSX VENTURE: SL) reports that the parties to the agreement to acquire the South Okanagan producing medical marijuana facility, have mutually agreed upon an extension of the due diligence period to April 29th, 2014. Supreme Enters Into Negotiations for an Additional Medical Marijuana Producing Facility
Marketwire - Mon Apr 14, 7:03AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(OTCBB: SPRWF) (TSX VENTURE: SL) reports that the Company has entered into negotiations with a producing medical marijuana facility to acquire that business. This is in addition to the South Okanagan producing facility currently under evaluation. The parties have agreed to an exclusive 45-day negotiating period. There is no guarantee that an agreement will be reached and will subject to regulatory approval. Supreme Pharmaceuticals Inc.: Due Diligence Update
Marketwire - Wed Apr 09, 3:16PM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(PINKSHEETS: SPRWF) notes that in respect to its prior press release on Friday April 4, 2014, the Company will be utilizing the full 7 business days to complete and conclude the due diligence period. This means that the Company will report news on Tuesday, April 15, 2014 with a final decision on the South Okanagan producing medical marijuana facility. Supreme Extends Due Diligence Period
Marketwire - Fri Apr 04, 2:35PM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(OTCBB: SPRWF) reports that the parties have extended the due diligence period in respect to the Company's peviously announced option agreement for an additional 7 business days until April 10, 2014. While due diligence results have been positive to date, the Company requires additional time to ensure the proper assessment of the South Okanagan producing facility before entering into the option. Supreme Pharmaceuticals Inc.: Executive Management Visits Producing Facility as Part of Due Diligence
Marketwire - Tue Apr 01, 8:27AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(OTCBB: SPRWF)(TSX VENTURE: SL) advises that management is currently visiting the producing medical marijuana facility on which the Company may acquire an option to purchase, as part of its due diligence. The facility is located in the south Okanagan and the Company will get an onsite evaluation of the complex as it enters the final stages of the due diligence period. The 10 day due diligence period expires as of Friday April 4th, 2014. There is no assurance that the normal due diligence and other conditions will be met successfully and the option acquired. The Company will provide further updates as this matter progresses. Cannabis Companies Continue To Ramp Up Operations: High Tech Security Company Expands Presence In Colorado
PR Newswire - Tue Mar 25, 9:45AM CDT
New licensing Agreements, Grow Monitoring Applications and High Tech Security surveillance operations aims to capitalize on cannabis - medical marijuana boom with expansion in Colorado: DirectView Holdings, Inc. (OTC: DIRV), Growlife, Inc. (OTC: PHOT), Nuvilex, Inc. (OTC: NVLX), IMD Companies, Inc. (OTC: ICBU) and Supreme Pharmaceuticals Inc. (OTC: SPRWF)
Supreme Updates Option to Purchase Press Release and Announces Private Placement
Marketwire - Tue Mar 25, 8:58AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(OTCBB: SPRWF) is pleased to announce that the Company has signed a conditional agreement with an arms-length South Okanagan-based company, whereby the Company has the option to purchase its producing medical marijuana business until March 23, 2015 for the sum of $1,000,000, payable in cash and shares, subject to regulatory approval. The Company is currently in a 10-business day due diligence period and if satisfied, Supreme will, subject to prior approval of the TSXV, make a $100,000 option payment. Supreme Acquires Option to Purchase Producing Medical Marijuana Facility
Marketwire - Mon Mar 24, 2:02AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(OTCBB: SPRWF) is pleased to announce that the Company has signed a conditional agreement with an arms-length South Okanagan-based company, whereby the Company has the option to purchase its producing medical marijuana business for up to twelve months for the sum of $1,000,000, payable in cash and shares, subject to regulatory approval. The Company is currently in a 10-business day due diligence period and if satisfied, Supreme will make a $100,000 option payment. Supreme to Evaluate Medical Marijuana Opportunities
Marketwire - Fri Mar 21, 7:01AM CDT
Supreme Pharmaceuticals Inc. (the "Company"
(TSX VENTURE: SL)(OTCBB: SPRWF) is pleased to announce that its continued efforts to secure an exclusive license agreement for a medical device are making significant headway; the Company will continue to keep its shareholders up to date on negotiations. In addition to medical devices, the Company has recently come across opportunities within the medical marijuana industry. Companies and key contacts have approached management with opportunities and the Company is evaluating them accordingly. Given the medical marijuana industry's immense growth, management is excited to evaluate the merit of the opportunities. Supreme Announces Name Change and Provides Update
Marketwire - Fri Mar 14, 3:01AM CDT
Supreme Pharmaceuticals Inc. ("Supreme" or the "Corporation"
(TSX VENTURE: SL)(OTCBB: SPRWF), formerly Supreme Resources Ltd., announces that it has changed its name to Supreme Pharmaceuticals Inc. in conjunction with its recent decision to pursue interests in pharmaceuticals and biomedical devices. The TSX Venture Exchange has advised the Corporation that trading under the new name and symbol "SL" will commence on March 14, 2014. 
